Evidence for a von Willebrand factor defect in factor VIII binding in three members of a family previously misdiagnosed mild haemophilia A and haemophilia A carriers: consequences for therapy and genetic counselling

British Journal of Haematology
C MazurierM Goudemand

Abstract

A plasma von Willebrand factor (vWf) defect limited to its failure to bind factor VIII (FVIII) was previously characterized in a woman with FVIII deficiency and normal primary haemostasis. By using in vitro tests we found a similar pattern in three siblings of another family previously thought to be affected with mild haemophilia A. Furthermore, a decrease in vWf ability to bind FVIII was found in the parents and the brother of the three patients. This decrease was consistent with heterozygous expression of a recessive vWf gene abnormality. FVIII deficiency was corrected by infusion with a vWf concentrate almost devoid of FVIII coagulant activity. FVIII recovery and half-life thus obtained showed that this treatment was more effective than a FVIII infusion performed by way of comparison. These results indicate that this vWf defect may account for FVIII deficiency in patients without the usual laboratory and clinical features of von Willebrand's disease. Changes in therapy and genetic counselling following the new diagnosis in this family emphasize the need to search for such a vWf defect in patients in whom FVIII deficiency is not obviously X-linked.

References

Jan 20, 1975·Annals of the New York Academy of Sciences·J B GrahamR C Elston
Feb 11, 1988·Nucleic Acids Research·S A MillerH F Polesky
Dec 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·K M BrinkhousM S Read
Jan 1, 1984·Scandinavian Journal of Haematology. Supplementum·S Rosén
Mar 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·C A Fulcher, T S Zimmerman

❮ Previous
Next ❯

Citations

Feb 15, 2002·International Journal of Hematology·Edith FressinaudDominique Meyer
Apr 1, 1996·Transfusion Medicine Reviews·E W Murray, D Lillicrap
Oct 31, 2002·British Journal of Haematology·Claudine MazurierJenny Goudemand
Jul 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·E A TuleyC Mazurier
Oct 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·I RabinowitzJ E Sadler
Jan 1, 1997·Medicine·W C Nichols, D Ginsburg
Jun 1, 1992·British Journal of Haematology·C MazurierF Forestier
Jun 25, 2008·Haemophilia : the Official Journal of the World Federation of Hemophilia·P H B Bolton-MaggsE Berntorp
Nov 1, 2001·Best Practice & Research. Clinical Haematology·C MazurierD Meyer
Nov 28, 2002·Clinical and Laboratory Haematology·S L TaylorA Alhaq
Oct 31, 2001·Clinical and Laboratory Haematology·S Keeney, A M Cumming
Apr 18, 2018·Haemophilia : the Official Journal of the World Federation of Hemophilia·E GallettaS Casonato
Mar 23, 2011·Pediatric Blood & Cancer·Madhu GuptaManuel D Carcao
Apr 1, 1995·Haemophilia : the Official Journal of the World Federation of Hemophilia·J C EikenboomE Briët
Apr 12, 2006·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Kanjaksha GhoshDipika Mohanty
Mar 5, 2011·Haemophilia : the Official Journal of the World Federation of Hemophilia·A VeyradierJ Goudemand
Nov 9, 2017·Haemophilia : the Official Journal of the World Federation of Hemophilia·A CasonatoV Daidone
Aug 21, 2020·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Omid Seidi ZadehSanaz Homayoun
Oct 22, 2020·European Journal of Human Genetics : EJHG·Isabella GaragiolaFlora Peyvandi
Jan 27, 2021·Journal of Thrombosis and Haemostasis : JTH·Omid SeidizadehPier Mannuccio Mannucci
Aug 1, 1993·Critical Reviews in Oncology/hematology·S Lethagen
Sep 9, 2021·Haemophilia : the Official Journal of the World Federation of Hemophilia·Almudena Pérez-RodríguezUNKNOWN investigators and centers involved in the PCM-EVW-ES project

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.